Patent · US Active

Haptens of quetiapine

US9304126B2 · kind B2 · utility

17Cited by

3References

21Claims

0Family size

Assignees

Janssen Pharmaceuticals, Inc. · BE
ORTHO-CLINICAL DIAGNOSTICS, INC. · US

Inventors

Matthew G. Donahue · Hattiesburg, US
Yong Gong · Warrington, US
Rhys Salter · Doylestown, US
Eric Hryhorenko · Hilton, US
Thomas R. DeCory · Pittsford, US
Bart M. Remmerie · Evergem, BE
Banumathi Sankaran · Lexington, US

Key dates

Filing date	Aug 20, 2013
Grant date	Apr 5, 2016
Priority date	—
Expiry date	Aug 20, 2033

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D417/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to compounds of Formula I, wherein R1, R2, and R3 are defined in the specification, useful for the synthesis of novel conjugates and immunogens derived from quetiapine. The invention also relates to conjugates of a quetiapine hapten and a protein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.